Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals.
about
The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection.HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach.CCL28 induces mucosal homing of HIV-1-specific IgA-secreting plasma cells in mice immunized with HIV-1 virus-like particlesUse of a new dual-antigen enzyme-linked immunosorbent assay to detect and characterize the human antibody response to the human immunodeficiency virus type 2 envelope gp125 and gp36 glycoproteinsEvidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohortEffects of type I interferons on the adjuvant properties of plasmid granulocyte-macrophage colony-stimulating factor in vivo.Immunologic uniqueness of the genital tract: challenge for vaccine development.The effects of HIV infection on oral mucosal immunity.HIV-2 A-subtype gp125c₂-v₃-c₃ mutations and their association with CCR5 and CXCR4 tropism.The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau.
P2860
Q33301326-956D3279-A948-4251-B8DC-887CC544EDBDQ33646773-6233C290-AFE9-44D1-9BC7-487AA220FBF8Q34069656-914A7292-853B-4B78-AE66-3AC2EDC9D067Q34430673-AB707676-EFCE-4E42-A0BD-C2D79BE411A5Q35635083-742BD6C5-BBCD-4372-A682-CED824B875D9Q36083803-97E1B8E0-AEEE-46D5-8C05-1847E3E196FEQ36099003-0AE72F40-9453-4634-AFBC-4C3C9C560C0FQ36099546-5939E856-E526-4D11-BFA3-5A458DFD16A7Q36467653-F51B205A-B351-4233-BCB2-D450621F342AQ38973555-8DF19122-886F-458F-8A44-62F3C970B616Q43143940-61B6965F-C29D-441F-A366-1E1C01445E42Q43825794-4B9D1A6A-0AFC-4594-AB21-77A0148323CC
P2860
Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Potent neutralizing serum immu ...... IgG-seronegative individuals.
@ast
Potent neutralizing serum immu ...... IgG-seronegative individuals.
@en
Potent neutralizing serum immunoglobulin A
@nl
type
label
Potent neutralizing serum immu ...... IgG-seronegative individuals.
@ast
Potent neutralizing serum immu ...... IgG-seronegative individuals.
@en
Potent neutralizing serum immunoglobulin A
@nl
prefLabel
Potent neutralizing serum immu ...... IgG-seronegative individuals.
@ast
Potent neutralizing serum immu ...... IgG-seronegative individuals.
@en
Potent neutralizing serum immunoglobulin A
@nl
P2093
P2860
P1433
P1476
Potent neutralizing serum immu ...... IgG-seronegative individuals.
@en
P2093
Charlotta Nilsson
Ewa Björling
Mariethe Ehnlund
Olav Larsen
Qin Lizeng
Samer Sourial
Sören Andersson
P2860
P304
P356
10.1128/JVI.78.13.7016-7022.2004
P407
P50
P577
2004-07-01T00:00:00Z